Reference
Foley K, et al. Brincidofovir is an oral antiviral therapy which is effective and well tolerated in patients with refractory viral reactivation in the post stem cell transplant setting. Bone Marrow Transplantation 51: S390 abstr. P502, 2016. Available from: URL: http://doi.org/10.1038/bmt.2016.49 [abstract] - United Kingdom
Rights and permissions
About this article
Cite this article
Brincidofovir. Reactions Weekly 1599, 40 (2016). https://doi.org/10.1007/s40278-016-16903-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-016-16903-2